Literature DB >> 25175807

Variables associated with hippocampal atrophy rate in normal aging and mild cognitive impairment.

Rachel L Nosheny1, Philip S Insel2, Diana Truran2, Norbert Schuff2, Clifford R Jack3, Paul S Aisen4, Leslie M Shaw5, John Q Trojanowski5, Michael W Weiner6.   

Abstract

The goal of this study was to identify factors contributing to hippocampal atrophy rate (HAR) in clinically normal older adults (NC) and participants with mild cognitive impairment (MCI). Longitudinal HAR was measured on T1-weighted magnetic resonance imaging, and the contribution of age, gender, apolipoprotein E (ApoE) ε4 status, intracranial volume, white matter lesions, and β-amyloid (Aβ) levels to HAR was determined using linear regression. Age-related effects of HAR were compared in Aβ positive (Aβ+) and Aβ negative (Aβ-) participants. Age and Aβ levels had independent effects on HAR in NC, whereas gender, ApoE ε4 status, and Aβ levels were associated with HAR in MCI. In multivariable models, Aβ levels were associated with HAR in NC; ApoE ε4 and Aβ levels were associated with HAR in MCI. In MCI, age was a stronger predictor of HAR in Aβ- versus Aβ+ participants. HAR was higher in Aβ+ participants, but most of the HAR was because of factors other than Aβ status. Age-related effects on HAR did not differ between NC versus MCI participants with the same Aβ status. Therefore, we conclude that even when accounting for other covariates, Aβ status, and not age, is a significant predictor of HAR; and that most of the HAR is not accounted for by Aβ status in either NC or MCI.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Hippocampal atrophy rate; Longitudinal study; Normal aging; β-amyloid

Mesh:

Substances:

Year:  2014        PMID: 25175807      PMCID: PMC5832349          DOI: 10.1016/j.neurobiolaging.2014.07.036

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  49 in total

1.  Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.

Authors:  Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale
Journal:  Neuron       Date:  2002-01-31       Impact factor: 17.173

2.  Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1-42.

Authors:  Jonathan M Schott; Jonathan W Bartlett; Nick C Fox; Josephine Barnes
Journal:  Ann Neurol       Date:  2010-12       Impact factor: 10.422

3.  Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.

Authors:  Jonathan H Morra; Zhuowen Tu; Liana G Apostolova; Amity E Green; Christina Avedissian; Sarah K Madsen; Neelroop Parikshak; Arthur W Toga; Clifford R Jack; Norbert Schuff; Michael W Weiner; Paul M Thompson
Journal:  Neuroimage       Date:  2008-11-08       Impact factor: 6.556

4.  Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly.

Authors:  Anne M Fagan; Denise Head; Aarti R Shah; Daniel Marcus; Mark Mintun; John C Morris; David M Holtzman
Journal:  Ann Neurol       Date:  2009-02       Impact factor: 10.422

5.  Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects.

Authors:  Abhinay D Joshi; Michael J Pontecorvo; Chrisopher M Clark; Alan P Carpenter; Danna L Jennings; Carl H Sadowsky; Lee P Adler; Karel D Kovnat; John P Seibyl; Anupa Arora; Krishnendu Saha; Jason D Burns; Mark J Lowrey; Mark A Mintun; Daniel M Skovronsky
Journal:  J Nucl Med       Date:  2012-02-13       Impact factor: 10.057

6.  Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative.

Authors:  Owen Carmichael; Christopher Schwarz; David Drucker; Evan Fletcher; Danielle Harvey; Laurel Beckett; Clifford R Jack; Michael Weiner; Charles DeCarli
Journal:  Arch Neurol       Date:  2010-11

7.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Authors:  Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Christopher M Clark; Paul S Aisen; Ronald C Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

8.  Rates of decline in Alzheimer disease decrease with age.

Authors:  Dominic Holland; Rahul S Desikan; Anders M Dale; Linda K McEvoy
Journal:  PLoS One       Date:  2012-08-02       Impact factor: 3.240

9.  Amyloid-β associated cortical thinning in clinically normal elderly.

Authors:  J Alex Becker; Trey Hedden; Jeremy Carmasin; Jacqueline Maye; Dorene M Rentz; Deepti Putcha; Bruce Fischl; Douglas N Greve; Gad A Marshall; Stephen Salloway; Donald Marks; Randy L Buckner; Reisa A Sperling; Keith A Johnson
Journal:  Ann Neurol       Date:  2011-03-17       Impact factor: 10.422

10.  Enrichment and stratification for predementia Alzheimer disease clinical trials.

Authors:  Dominic Holland; Linda K McEvoy; Rahul S Desikan; Anders M Dale
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

View more
  18 in total

1.  Mapping 3-year changes in gray matter and metabolism in Aβ-positive nondemented subjects.

Authors:  Miguel Ángel Araque Caballero; Matthias Brendel; Andreas Delker; Jinyi Ren; Axel Rominger; Peter Bartenstein; Martin Dichgans; Michael W Weiner; Michael Ewers
Journal:  Neurobiol Aging       Date:  2015-08-18       Impact factor: 4.673

2.  Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.

Authors:  Stefanie Schreiber; Frank Schreiber; Samuel N Lockhart; Andy Horng; Alexandre Bejanin; Susan M Landau; William J Jagust
Journal:  JAMA Neurol       Date:  2017-06-01       Impact factor: 18.302

Review 3.  Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2017-03-22       Impact factor: 21.566

4.  Effect Modifiers of TDP-43-Associated Hippocampal Atrophy Rates in Patients with Alzheimer's Disease Neuropathological Changes.

Authors:  Marina Buciuc; Alexandra M Wennberg; Stephen D Weigand; Melissa E Murray; Matthew L Senjem; Anthony J Spychalla; Bradley F Boeve; David S Knopman; Clifford R Jack; Kejal Kantarci; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Jennifer L Whitwell; Keith A Josephs
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 5.  The evolution of preclinical Alzheimer's disease: implications for prevention trials.

Authors:  Reisa Sperling; Elizabeth Mormino; Keith Johnson
Journal:  Neuron       Date:  2014-11-05       Impact factor: 17.173

6.  Five-Year Longitudinal Brain Volume Change in Healthy Elders at Genetic Risk for Alzheimer's Disease.

Authors:  Katherine Reiter; Kristy A Nielson; Sally Durgerian; John L Woodard; J Carson Smith; Michael Seidenberg; Dana A Kelly; Stephen M Rao
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 7.  Multimodality imaging of Alzheimer disease and other neurodegenerative dementias.

Authors:  Ilya M Nasrallah; David A Wolk
Journal:  J Nucl Med       Date:  2014-11-20       Impact factor: 10.057

8.  Associations among amyloid status, age, and longitudinal regional brain atrophy in cognitively unimpaired older adults.

Authors:  Rachel L Nosheny; Philip S Insel; Niklas Mattsson; Duygu Tosun; Shannon Buckley; Diana Truran; N Schuff; Paul S Aisen; Michael W Weiner
Journal:  Neurobiol Aging       Date:  2019-07-22       Impact factor: 4.673

9.  Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2.

Authors:  Clifford R Jack; Josephine Barnes; Matt A Bernstein; Bret J Borowski; James Brewer; Shona Clegg; Anders M Dale; Owen Carmichael; Christopher Ching; Charles DeCarli; Rahul S Desikan; Christine Fennema-Notestine; Anders M Fjell; Evan Fletcher; Nick C Fox; Jeff Gunter; Boris A Gutman; Dominic Holland; Xue Hua; Philip Insel; Kejal Kantarci; Ron J Killiany; Gunnar Krueger; Kelvin K Leung; Scott Mackin; Pauline Maillard; Ian B Malone; Niklas Mattsson; Linda McEvoy; Marc Modat; Susanne Mueller; Rachel Nosheny; Sebastien Ourselin; Norbert Schuff; Matthew L Senjem; Alix Simonson; Paul M Thompson; Dan Rettmann; Prashanthi Vemuri; Kristine Walhovd; Yansong Zhao; Samantha Zuk; Michael Weiner
Journal:  Alzheimers Dement       Date:  2015-07       Impact factor: 21.566

10.  Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum.

Authors:  David S Knopman; Clifford R Jack; Emily S Lundt; Stephen D Weigand; Prashanthi Vemuri; Val J Lowe; Kejal Kantarci; Jeffrey L Gunter; Matthew L Senjem; Michelle M Mielke; Mary M Machulda; Rosebud O Roberts; Bradley F Boeve; David T Jones; Ronald C Petersen
Journal:  Neurobiol Aging       Date:  2016-06-16       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.